1-(4-(difluoromethoxy)-2-fluorophenyl)ethan-1-one

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1-(4-(difluoromethoxy)-2-fluorophenyl)ethan-1-one
• 英文别名: 1-(4-difluoromethoxy-2-fluoro-phenyl)-ethanone；1-[4-(Difluoromethoxy)-2-fluorophenyl]ethan-1-one；1-[4-(difluoromethoxy)-2-fluorophenyl]ethanone
• 化学式: C₉H₇F₃O₂
• 分子量: 204.149
• InChiKey: OQOJJZMUJRVTRI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  1-(4-(difluoromethoxy)-2-fluorophenyl)ethan-1-one 在 乌洛托品 、 copper(ll) bromide 作用下， 以 乙醇 、 乙酸乙酯 为溶剂， 反应 26.0h， 生成 2-amino-1-(4-(difluoromethoxy)-2-fluorophenyl)ethan-1-one
  参考文献：
  名称：

  [EN] METALLOENZYME INHIBITOR COMPOUNDS
  [FR] COMPOSÉS INHIBITEURS DE MÉTALLOENZYMES

  摘要：

  提供具有HDAC6调节活性的化合物，以及通过HDAC6介导的治疗疾病、疾病或症状的方法。

  公开号：

  WO2018165520A1
• 作为产物：
  描述：

  氟里昂-22 、 2-氟-4-羟基苯乙酮 在 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 3.0h， 生成 1-(4-(difluoromethoxy)-2-fluorophenyl)ethan-1-one
  参考文献：
  名称：

  Synthesis of benzylaminopyrimidines and their fungicidal activities against wheat brown rust and barley powdery mildew

  摘要：

  Members of a new class of fungicide containing benzyl-aminopyrimidine as a core structure were synthesized and their fungicidal potencies against wheat brown rust, Puccinia recondita, and barley powdery mildew, Erysiphe graminis, were assessed. Among these fungicides, N-(fluoroalkoxy or fluorophenoxybenzyl)-4-pyrimidinamines showed notable preventive activities. The potency of the new pyrimidines was increased when a difluoromethoxy or tetrafluorophenoxy group was introduced at the 4- or 3-position of the phenyl moiety and a methyl or ethyl group was introduced at the benzyl position. Structure-activity relationships are discussed. (C) 1998 Society of Chemical Industry.

  DOI：

  10.1002/(sici)1096-9063(1998110)54:3<223::aid-ps814>3.0.co;2-r

文献信息

• 4,5-DIHYDRO-OXAZOL-2-YL AMINE DERIVATIVES
  申请人：Andreini Matteo

  公开号：US20090209529A1

  公开（公告）日：2009-08-20

  The present invention relates to a compounds of formula I wherein R 1 , R 1′ , R 2 , R 3 , R 4 , X, Ar, and m are as defined in the specification and claims and pharmaceutically active acid addition salts thereof. Compounds of the invention have Asp2 (β-secretase, BACE 1 or Memapsin-2) inhibitory activity and are useful for the treatment of diseases characterized by elevated β-amyloid levels or β-amyloid deposits, particularly Alzheimer's disease.

  本发明涉及一种具有以下式I的化合物 其中R 1 ，R 1′ ，R 2 ，R 3 ，R 4 ，X，Ar和m如规范和索赔中定义，并且其药用活性酸盐。本发明的化合物具有Asp2（β-分泌酶，BACE 1或Memapsin-2）抑制活性，并且对于治疗由β-淀粉样蛋白水平升高或β-淀粉样蛋白沉积所特征的疾病，特别是阿尔茨海默病，是有用的。
• 6-alkyl dihydropyrazolopyrimidinone compounds as PDE2 inhibitors
  申请人：Merck Sharp & Dohme Corp.

  公开号：US10160762B2

  公开（公告）日：2018-12-25

  The present invention is directed to 6-alkyl dihydropyrazolopyrimidinone compounds of formula (I) which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 2 (PDE2). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis, Parkinson's disease, Parkinson's disease dementia (PDD), or Huntington's disease, and those associated with striatal hypo-function or basal ganglia dysfunction.

  本发明涉及式（I）的6-烷基二氢吡唑嘧啶酮化合物，该化合物可作为治疗剂用于治疗与磷酸二酯酶2（PDE2）相关的中枢神经系统疾病。本发明还涉及使用此类化合物治疗神经和精神疾病，如精神分裂症、精神病、帕金森病、帕金森病痴呆（PDD）或亨廷顿病，以及与纹状体功能低下或基底节功能障碍相关的疾病。
• Metalloenzyme inhibitor compounds
  申请人：Selenity Therapeutics (Bermuda), Ltd.

  公开号：US10357493B2

  公开（公告）日：2019-07-23

  Provided are compounds having HDAC6 modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by HDAC6.

  本文提供了具有 HDAC6 调节活性的化合物，以及治疗由 HDAC6 介导的疾病、失调或症状的方法。
• 4, 5-DIHYDRO-OXAZOL-2-YL AMINE DERIVATIVES
  申请人：F. Hoffmann-La Roche AG

  公开号：EP2245019A1

  公开（公告）日：2010-11-03
• 6-ALKYL DIHYDROPYRAZOLOPYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS
  申请人：Merck Sharp & Dohme Corp.

  公开号：EP3302484A1

  公开（公告）日：2018-04-11